Novo Nordisk comeback stirs as Wegovy pill wins UK approval - Pharmaceutical Technology

There are already lengthy patient waitlists for the medication on digital health platforms. There are already lengthy patient waitlists for the medication on digital health platforms. While being authorised for the UK market, it is unclear how Novo’s pill will be covered on the NHS. Credit: Michaelvbg/Shutterstock.com. The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has approved Novo Nordisk’s Wegovy (semaglutide) pill, marking another regulatory win for the drugmaker as it looks to close the gap to obesity market rival Eli Lilly. The agency has authorised the tablet for adult patients with obesity and a Body Mass Index (BMI)…

Source: Pharmaceutical Technology